Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.
Latest website image capture
Clouds background image

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added to the Record History, replacing the prior Revision: v3.5.2. This reflects a minor site update to the page history.
    Difference
    0.1%
    Check dated 2026-04-30T14:26:36.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Record History now shows a new revision (v3.5.2) and removes an older revision (v3.5.0) from the version list.
    Difference
    0.1%
    Check dated 2026-04-16T10:30:58.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    New revision entry v3.5.0 added to the study record history. Revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-25T20:55:58.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the Version History. Revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:36:19.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed a government funding lapse notice and Revision: v3.4.1.
    Difference
    0.8%
    Check dated 2026-02-11T02:07:29.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-03T23:53:22.000Z thumbnail image

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.